Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Trust and our long-term performance
Emma Walmsley, CEO, will speak at CECP’s CEO Investor Forum on 20 September 2018 at 10:30am EDT. She will talk about the steps we are taking to build trust – one of our three long-term priorities – and drive sustainable business performance.